BILL to Participate in Upcoming Investor Conferences
BILL to Participate in Upcoming Investor Conferences
BILL (NYSE:BILL), a leading financial operations platform for small and midsize businesses (SMBs), today announced its participation in the following upcoming investor conferences:
Citi FinTech Conference |
|
Tuesday, February 27, 2024 at 5:45 a.m. PT |
|
Morgan Stanley Technology, Media & Telecom Conference |
|
Tuesday, March 5, 2024 at 11:00 a.m. PT |
|
KeyBanc Emerging Technology Summit |
|
Wednesday, March 6, 2024 at 1:00 p.m. PT |
|
Wolfe FinTech Forum |
|
Wednesday, March 13, 2024 at 11:25 a.m. PT |
Live webcasts, as well as replays, will be available on the Company's investor relations website at https://investor.bill.com/. Please note presentation times are subject to change.
About BILL:
BILL (NYSE: BILL) is a leading financial operations platform for small and midsize businesses (SMBs). As a champion of SMBs, we are automating the future of finance so businesses can thrive. Our integrated platform helps businesses to more efficiently control their payables, receivables and spend and expense management. Hundreds of thousands of businesses rely on BILL’s proprietary member network of millions to pay or get paid faster. Headquartered in San Jose, California, BILL is a trusted partner of leading U.S. financial institutions, accounting firms, and accounting software providers. For more information, visit bill.com.
IR Contact:
Karen Sansot
ksansot@hq.bill.com
Press Contact:
John Welton
john.welton@hq.bill.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223198860/en/
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth